IISc-incubated Mynvax to get funding to bring “warm” Covid vaccine to market
3 years, 5 months ago

IISc-incubated Mynvax to get funding to bring “warm” Covid vaccine to market

The Hindu  

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development at the Indian Institute of Science, has signed an agreement to raise $4.2 million in its Series A round of financing led by Accel to bring thermotolerant Covid vaccine to the market. The company said that with the support of BIRAC, Government of India, early-stage investors and SID, IISc, it was able to rapidly demonstrate its ability to develop novel vaccine candidates which have been rigorously tested for performance and unique attributes such as heat tolerance, to increase access to the vaccine across the country. Dr. Gautham Nadig, co-founder and Executive Director of Mynvax said that in addition to expeditiously advancing its existing vaccine candidates, both in India and overseas, the company would also invest in developing new vaccine modalities. Mahendran Balachandran, Partner, Accel said, “We strongly believe that Mynvax's platform has the potential to make a huge positive change in the Global vaccine landscape for major respiratory illnesses.” Mynvax was founded in 2017 by Dr. Raghavan Varadarajan, Professor at the Indian Institute of Science, Bangalore and Dr. Nadig, an alumnus of the Institute, with the aim of advancing innovative and broadly protective influenza vaccine technologies.

History of this topic

Serum Institute to double investment in Biocon’s unit to $300 million
1 year, 8 months ago
Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here
2 years ago
Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
3 years ago
Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax
3 years ago
India’s Serum Institute resumes vaccine exports to COVAX
3 years, 1 month ago
India applies for $2bn loan from AIIB, ADB for vaccine purchase
3 years, 2 months ago
Jabs That Did the Trick: A Look at India’s Vaccine Arsenal That Helped it Achieve a Billion-Dose Feat
3 years, 2 months ago
Serum institute will deliver COVID-19 vaccines to COVAX, other nations by end-2021
3 years, 7 months ago
Serum Institute's 2nd COVID-19 vaccine likely to be launched in September
3 years, 9 months ago
Tie-up with India's Serum Institute key to mass production of Covid vaccines, say pharma majors
3 years, 10 months ago
Serum Institute Expects WHO Emergency Approval for Oxford-AstraZeneca Covid-19 Vaccine Shot Soon
3 years, 11 months ago
COVAX Programme Doubles Global Vaccine Supply Deals To Two Billion Doses
4 years ago
Serum Institute of India to focus on supplying COVID-19 vaccine to India first
4 years, 1 month ago
India first, says Serum Institute on AstraZeneca Covid vaccine distribution plan
4 years, 1 month ago
‘Initial support will cover 92 low- and middle-income economies for COVID-19 vaccines’, says Gavi the Vaccine Alliance CEO Seth Berkley
4 years, 1 month ago
Oxford covid vaccine: Serum Institute expects emergency authorization next month
4 years, 1 month ago
Gates Foundation Donates an Extra 70mn Dollar to Fund Equal Distribution of Covid Vaccines
4 years, 1 month ago
‘India’s potential participation in COVAX advance market commitment is under way’
4 years, 2 months ago
Readying 1 billion doses of 5 coronavirus vaccines, says SII's Adar Poonawalla
4 years, 2 months ago
UNICEF To Stockpile Over Half A Billion Syringes For Future COVID-19 Vaccine
4 years, 2 months ago
Serum Institute raises $150 mn funding for additional vaccines
4 years, 3 months ago
Serum Institute to produce additional 10 crore doses of covid vaccines
4 years, 3 months ago
Serum Institute of India to Produce Extra 200 Million Doses of Covid-19 Vaccine for Poorer Countries
4 years, 3 months ago
Serum Institute of India to produce additional 100 million COVID-19 vaccine doses for India
4 years, 3 months ago
Covid-19 vaccine: Serum Institute to make 10 crore additional doses for India, low income nations
4 years, 3 months ago
Serum Institute of India Says Covid-19 Vaccine Likely to Be Ready by End of 2020, Final Pricing in 2 Months
4 years, 4 months ago
Coronavirus: SII partners with vaccine developers for 100mn doses
4 years, 5 months ago
Serum Institute to make up to 100 million COVID-19 vaccine doses for India, low-income countries by 2021
4 years, 5 months ago
Serum Institute of India, Novavax in covid vaccine deal, may produce 100 crore doses
4 years, 5 months ago
Serum Institute signs deal with Gavi, Gates Foundation to deliver 100 million Covid vaccine doses
4 years, 5 months ago
UK government invests $18 million in Scottish vaccine site
4 years, 5 months ago
Won't Profit from Covid-19 Vaccine in Pandemic, Says AstraZeneca amid Strong Sales
4 years, 5 months ago
Won’t profit from COVID-19 vaccine in pandemic, says AstraZeneca
4 years, 5 months ago
Pfizer announces $1.95 billion deal to produce 100 million doses of coronavirus vaccine by year-end
4 years, 5 months ago
COVID-19 aftermath: Funding divide among Indian startups makes survival difficult; while some bag millions, others struggle
4 years, 6 months ago
Novavax gets U.S. defense funding for its COVID-19 vaccine
4 years, 7 months ago
Coronavirus | 80% success chance for Oxford vaccine trials, says Serum Institute chief
4 years, 7 months ago
AstraZeneca CEO says $1 billion vaccine bet is ‘absolutely worth it’
4 years, 7 months ago

Discover Related